Andy Stern Joins Board Of Biowarfare Defense Pharmaceutical Company

SEIU President Andy Stern
Start your day with TPM.
Sign up for the Morning Memo newsletter

In a move that has Washington scratching its head a bit, former SEIU President Andy Stern has joined the board of SIGA Technologies–a company that specializes in developing drugs to combat biological warfare pathogens.

“Andy is a strong leader and a great addition to our Board of Directors. His insight, experience, and leadership, particularly his understanding of how our federal government works, will complement the skill sets of our existing board members,” reads a statement from Dr. Eric Rose, SIGA’s Chief Executive Officer.

I’ve reached out to Stern for comment on this. An unexpected step to say the least.

Latest DC
Comments
Masthead Masthead
Founder & Editor-in-Chief:
Executive Editor:
Managing Editor:
Associate Editor:
Editor at Large:
General Counsel:
Publisher:
Head of Product:
Director of Technology:
Associate Publisher:
Front End Developer:
Senior Designer: